Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

6.56
Delayed Data
As of Feb 12
 +0.14 / +2.18%
Today’s Change
4.38
Today|||52-Week Range
7.16
+14.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues20.3M9.3M18.5M16.8M
 
 
 
 
 
Cost of Goods Sold2.3M673.0K1.6M3.9M
 
 
 
 
 
Depreciation And Amortization3.0M1.8M1.8M1.7M
 
 
 
 
 
 
Operating ExpensesGross Income15.1M6.8M15.1M11.2M
 
 
 
 
 
General Expenses13.2M9.0M11.6M12.7M
 
 
 
 
 
Research And Development3.5M2.2M2.2M2.2M
 
 
 
 
 
Total Operating Expenses18.4M11.5M15.0M18.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.9M-2.2M3.5M-1.6M
 
 
 
 
 
Interest Expense On Debt920.0K588.0K421.0K493.0K
 
 
 
 
 
Other Expenses1.2M81.0K489.0K100.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.8M-2.3M3.9M-1.7M
 
 
 
 
 
Income Taxes-616.0K-551.0K-440.0K-267.0K
 
 
 
 
 
Minority Interest-834.0K-589.0K-1.2M-382.0K
 
 
 
 
 
Net Income1.3M-2.3M2.3M-1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS55.7M56.2M56.0M56.4M
 
 
 
 
 
Shares To Calculate EPS Diluted56.1M56.2M56.2M56.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.02-$0.04$0.04-$0.03
 
 
 
 
 
EPS Diluted$0.02-$0.04$0.04-$0.03